Drugs / human alpha-1 antitrypsin
last change Jan 2024 re-read 3 minutes ago

human alpha-1 antitrypsin

Developed for
chronic pancreatitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT02947087 Comparator Jan 2017 → Nov 2021 chronic pancreatitis Medical University of South Carolina Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as human alpha-1 antitrypsin “human alpha-1 antitrypsin (AAT) or placebo infusion weekly for four doses” PMID 38659255 ↗ Jan 2024